Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Alexion Pharmaceuticals
Lobbying Relationship
Bills mentioned
S.771: Improving Access To Affordable Prescription Drugs Act
Sponsor: Al Franken (D-Minn.)
S.637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Sponsor: Ron Wyden (D-Ore.)
S.934: FDA Reauthorization Act of 2017
Sponsor: Lamar Alexander (R-Tenn.)
H.R.1231: RACE for Children Act
Sponsor: Michael McCaul (R-Texas)
S.456: RACE for Children Act
Sponsor: Michael Bennet (D-Colo.)
S.1390: STRONGER Patents Act of 2017
Sponsor: Christopher A. Coons (D-Del.)
S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.34: 21st Century Cures Act
Sponsor: Suzanne Bonamici (D-Ore.)
H.R.1537: Advancing Hope Act of 2015
Sponsor: G. K. Butterfield (D-N.C.)
S.1878: Advancing Hope Act of 2016
Sponsor: Bob Casey (D-Pa.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.9: Innovation Act
Sponsor: Robert W. Goodlatte (R-Va.)
S.1137: PATENT Act
Sponsor: Charles E. Grassley (R-Iowa)
S.866: Patent Quality Improvement Act of 2013
Sponsor: Charles E. Schumer (D-N.Y.)
H.R.2766: STOP Act
Sponsor: Darrell Issa (R-Calif.)
S.1013: Patent Abuse Reduction Act of 2013
Sponsor: John Cornyn (R-Texas)
H.R.2639: Patent Litigation and Innovation Act of 2013
Sponsor: Hakeem Jeffries (D-N.Y.)
H.R.3309: Innovation Act
Sponsor: Robert W. Goodlatte (R-Va.)
S.1720: Patent Transparency and Improvements Act of 2013
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.3204: Drug Quality and Security Act
Sponsor: Fred Upton (R-Mich.)
S.959: Pharmaceutical Quality, Security, and Accountability Act
Sponsor: Tom Harkin (D-Iowa)
H.R.3765: Temporary Payroll Tax Cut Continuation Act of 2011
Sponsor: Dave Camp (R-Mich.)
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.4872: Health Care and Education Reconciliation Act of 2010
Sponsor: John M. Spratt Jr. (D-S.C.)
H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...
Sponsor: Kevin Brady (R-Texas)
S.340: CREATES Act of 2019
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.965: CREATES Act of 2019
Sponsor: David Cicilline (D-R.I.)
S.64: Preserve Access to Affordable Generics and Biosimilars Act
Sponsor: Amy Klobuchar (D-Minn.)
H.R.2375: Preserve Access to Affordable Generics and Biosimilars Act
Sponsor: Jerrold Nadler (D-N.Y.)
S.1224: Stop STALLING Act
Sponsor: Amy Klobuchar (D-Minn.)
H.R.2374: Stop STALLING Act
Sponsor: Hakeem Jeffries (D-N.Y.)
S.1227: Prescription Pricing for the People Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
H.R.2376: Prescription Pricing for the People Act of 2019
Sponsor: Doug Collins (R-Ga.)
S.1416: Affordable Prescriptions for Patients Act of 2019
Sponsor: John Cornyn (R-Texas)
H.R.3391: To Offer Refugees College Help (TORCH) Act
Sponsor: Jared Huffman (D-Calif.)
H.R.4398: Affordable Prescriptions for Patients Through Promoting Competition Act...
Sponsor: David Cicilline (D-R.I.)
H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Bobby L. Rush (D-Ill.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Andrea LaRue | Rules Cmte Counsel, Sen. Dodd Counsel, Sen. Daschle Legis. Asst. and Dist. Dir., Cong. Andrews |
| Jane Loewenson | Health Fellow, Senator George Mitchell Professional Staff Member, Subcommittee on children and families of the Senate and Labor and Human Resources comte., Sen. Chris Dodd Senior Health Policy Advisor, Senator Thomas Daschle |
| Lisa Foster | Senior Policy Advisor, Senator Jack Reed |
| Patricia Griffin | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate